- Home
- LSTA vs ASBP Comparison
LSTA vs ASBP Comparison
Compare LSTA & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- ASBP
- Stock Information
- Founded
- LSTA 1980
- ASBP 2021
- Country
- LSTA United States
- ASBP United States
- Employees
- LSTA N/A
- ASBP N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- ASBP Biotechnology: Pharmaceutical Preparations
- Sector
- LSTA Health Care
- ASBP Health Care
- Exchange
- LSTA Nasdaq
- ASBP Nasdaq
- Market Cap
- LSTA 20.9M
- ASBP 18.9M
- IPO Year
- LSTA N/A
- ASBP N/A
- Fundamental
- Price
- LSTA $2.06
- ASBP $0.24
- Analyst Decision
- LSTA Strong Buy
- ASBP
- Analyst Count
- LSTA 2
- ASBP 0
- Target Price
- LSTA $23.50
- ASBP N/A
- AVG Volume (30 Days)
- LSTA 144.6K
- ASBP 2.6M
- Earning Date
- LSTA 11-06-2025
- ASBP 11-24-2025
- Dividend Yield
- LSTA N/A
- ASBP N/A
- EPS Growth
- LSTA N/A
- ASBP N/A
- EPS
- LSTA N/A
- ASBP N/A
- Revenue
- LSTA $1,070,000.00
- ASBP N/A
- Revenue This Year
- LSTA N/A
- ASBP N/A
- Revenue Next Year
- LSTA N/A
- ASBP N/A
- P/E Ratio
- LSTA N/A
- ASBP N/A
- Revenue Growth
- LSTA N/A
- ASBP N/A
- 52 Week Low
- LSTA $1.87
- ASBP $0.20
- 52 Week High
- LSTA $4.20
- ASBP $15.80
- Technical
- Relative Strength Index (RSI)
- LSTA 35.02
- ASBP 36.55
- Support Level
- LSTA $2.00
- ASBP $0.32
- Resistance Level
- LSTA $2.98
- ASBP $0.47
- Average True Range (ATR)
- LSTA 0.23
- ASBP 0.06
- MACD
- LSTA -0.05
- ASBP -0.01
- Stochastic Oscillator
- LSTA 9.18
- ASBP 8.27
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
About ASBP Aspire Biopharma Holdings Inc. Common Stock
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.